About
Innocare Pharma Ltd. A (SHG:688428) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
Apr 23 2026
InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability
Apr 21 2026
Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety
Mar 25 2026
InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit
Mar 16 2026
InnoCare Announces First Healthy Volunteer Dosed in Clinical Trial of Novel VAV1 Degrader ICP-538 in China
Financials
Revenue
CN¥2.37 B
Market Cap
CN¥51.77 B
P/E Ratio
77.32
EPS
0.38
Translate